Variant report
Variant | esv2754064 |
---|---|
Chromosome Location | chr12:60608389-60645117 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:97)
- CpG islands (count:0)
- Chromatin interactive region (count:10)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr12:60644817-60645007 | A549 | lung: | n/a | n/a |
2 | CEBPB | chr12:60637395-60637433 | A549 | lung: | n/a | n/a |
3 | CEBPB | chr12:60637345-60637507 | HepG2 | liver: | n/a | chr12:60637394-60637405 |
4 | CEBPB | chr12:60644861-60645657 | Hela-S3 | cervix: | n/a | n/a |
5 | CTCF | chr12:60628380-60628443 | GM13976 | blood: | n/a | n/a |
6 | CTCF | chr12:60643927-60644029 | MCF-7 | breast: | n/a | n/a |
7 | CTCF | chr12:60629632-60629658 | GM10266 | blood: | n/a | n/a |
8 | CTCF | chr12:60643901-60644010 | K562 | blood: | n/a | n/a |
9 | CUX1 | chr12:60614304-60614325 | K562 | blood: | n/a | n/a |
10 | E2F4 | chr12:60608645-60608868 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | E2F4 | chr12:60610712-60610965 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | EP300 | chr12:60644873-60645258 | Hela-S3 | cervix: | n/a | n/a |
13 | EP300 | chr12:60627787-60627980 | K562 | blood: | n/a | n/a |
14 | FOS | chr12:60643085-60643397 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | FOS | chr12:60643085-60643381 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | FOS | chr12:60644907-60645211 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | FOS | chr12:60613490-60614105 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOS | chr12:60613496-60614105 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | FOS | chr12:60613568-60614099 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | FOS | chr12:60613686-60614044 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | FOS | chr12:60643201-60643331 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | FOS | chr12:60643069-60643397 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr12:60624085-60624115 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | FOSL2 | chr12:60628655-60628858 | HepG2 | liver: | n/a | n/a |
25 | FOXA1 | chr12:60628691-60628900 | HepG2 | liver: | n/a | n/a |
26 | FOXA1 | chr12:60628680-60628883 | HepG2 | liver: | n/a | n/a |
27 | FOXA1 | chr12:60631240-60631467 | A549 | lung: | n/a | n/a |
28 | FOXA1 | chr12:60628715-60628873 | T-47D | breast: | n/a | n/a |
29 | FOXA1 | chr12:60628699-60628909 | HepG2 | liver: | n/a | n/a |
30 | FOXA1 | chr12:60631215-60631477 | A549 | lung: | n/a | n/a |
31 | FOXA2 | chr12:60628595-60629033 | A549 | lung: | n/a | n/a |
32 | FOXA2 | chr12:60628633-60629145 | A549 | lung: | n/a | n/a |
33 | FOXA2 | chr12:60628700-60628901 | HepG2 | liver: | n/a | n/a |
34 | GATA3 | chr12:60608871-60609410 | MCF-7 | breast: | n/a | n/a |
35 | GTF2B | chr12:60617098-60617364 | K562 | blood: | n/a | n/a |
36 | HEY1 | chr12:60617092-60617461 | K562 | blood: | n/a | n/a |
37 | IRF1 | chr12:60610386-60610449 | K562 | blood: | n/a | n/a |
38 | KAP1 | chr12:60617495-60617778 | K562 | blood: | n/a | n/a |
39 | MAFF | chr12:60625948-60626263 | K562 | blood: | n/a | chr12:60626111-60626129 |
40 | MAFF | chr12:60625977-60626269 | HepG2 | liver: | n/a | chr12:60626111-60626129 |
41 | MAFK | chr12:60625945-60626301 | HepG2 | liver: | n/a | chr12:60626112-60626127 |
42 | MAFK | chr12:60626074-60626185 | H1-hESC | embryonic stem cell: | n/a | chr12:60626112-60626127 |
43 | MAFK | chr12:60625954-60626275 | HepG2 | liver: | n/a | chr12:60626112-60626127 |
44 | MAFK | chr12:60625981-60626265 | K562 | blood: | n/a | chr12:60626112-60626127 |
45 | MAFK | chr12:60628696-60628754 | HepG2 | liver: | n/a | n/a |
46 | MAFK | chr12:60644874-60644878 | HepG2 | liver: | n/a | n/a |
47 | MAFK | chr12:60626057-60626184 | Hela-S3 | cervix: | n/a | chr12:60626112-60626127 |
48 | MAFK | chr12:60625948-60626281 | IMR90 | lung: | n/a | chr12:60626112-60626127 |
49 | MAX | chr12:60636123-60636405 | K562 | blood: | n/a | n/a |
50 | MYC | chr12:60636048-60636452 | K562 | blood: | n/a | n/a |
No data |
(count:10 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:60610771..60614544-chr12:60615184..60617062,3 | K562 | blood: | |
2 | chr12:60610771..60614544-chr12:60615184..60617062,3 | K562 | blood: | |
3 | chr12:60602868..60604477-chr12:60621320..60623690,2 | K562 | blood: | |
4 | chr12:60617591..60619683-chr12:60621297..60623226,2 | MCF-7 | breast: | |
5 | chr12:60618343..60621126-chr12:60626105..60627669,2 | K562 | blood: | |
6 | chr12:60610562..60614544-chr12:60614554..60617623,4 | K562 | blood: | |
7 | chr12:60618343..60621126-chr12:60626105..60627669,2 | K562 | blood: | |
8 | chr12:60617591..60619683-chr12:60621297..60623226,2 | MCF-7 | breast: | |
9 | chr12:60644951..60647277-chr12:60691077..60693506,2 | MCF-7 | breast: | |
10 | chr12:60610562..60614544-chr12:60614554..60617623,4 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000258184 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7301616 | chr12:60608389-60608390 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs148374667 | chr12:60608415-60608416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11173367 | chr12:60608416-60608417 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs564500471 | chr12:60608419-60608420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533714433 | chr12:60608440-60608441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560353034 | chr12:60608442-60608443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549324616 | chr12:60608479-60608480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559394997 | chr12:60608547-60608548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs193052386 | chr12:60608658-60608659 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs548322460 | chr12:60608666-60608667 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs11173368 | chr12:60608717-60608718 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs568135383 | chr12:60608718-60608719 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs569935977 | chr12:60608724-60608725 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs142191710 | chr12:60608780-60608781 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs376711041 | chr12:60608892-60608893 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs550788470 | chr12:60608916-60608917 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs570548208 | chr12:60608958-60608959 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs74096934 | chr12:60609005-60609006 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs546528362 | chr12:60609036-60609037 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs566534852 | chr12:60609055-60609056 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs11173369 | chr12:60609093-60609094 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs555461266 | chr12:60609124-60609125 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs201753534 | chr12:60609142-60609143 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs146365337 | chr12:60609161-60609162 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs537936887 | chr12:60609213-60609214 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs183638639 | chr12:60609230-60609231 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs139656725 | chr12:60609238-60609239 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs540931316 | chr12:60609272-60609273 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs560733766 | chr12:60609321-60609322 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs572899454 | chr12:60609393-60609394 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs116650230 | chr12:60609412-60609413 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs186787224 | chr12:60609430-60609431 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs555116326 | chr12:60609474-60609475 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs574949020 | chr12:60609519-60609520 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs142868619 | chr12:60609561-60609562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564306069 | chr12:60609564-60609565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532940829 | chr12:60609570-60609571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191257850 | chr12:60609572-60609573 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368022131 | chr12:60609577-60609578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566400385 | chr12:60609698-60609699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535341791 | chr12:60609711-60609712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs11173370 | chr12:60609712-60609713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189499946 | chr12:60609714-60609715 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34306594 | chr12:60609716-60609717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577162461 | chr12:60609723-60609724 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557930995 | chr12:60609739-60609740 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs578134979 | chr12:60609753-60609754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546212117 | chr12:60609786-60609787 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564903911 | chr12:60609826-60609827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534102976 | chr12:60609828-60609829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma | 17090523 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Breast cancer | 21364760 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:60599600-60645400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr12:60609000-60610200 | Enhancers | HUVEC | blood vessel |
3 | chr12:60609200-60609400 | Enhancers | K562 | blood |
4 | chr12:60610000-60610200 | Enhancers | K562 | blood |
5 | chr12:60610000-60610800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr12:60624800-60625400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr12:60624800-60625400 | Enhancers | Fetal Heart | heart |
8 | chr12:60625000-60625200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr12:60625000-60625200 | Enhancers | K562 | blood |
10 | chr12:60625000-60627200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
11 | chr12:60625200-60626400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr12:60625200-60632600 | Weak transcription | K562 | blood |
13 | chr12:60626400-60626800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr12:60626400-60626800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr12:60626800-60628200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
16 | chr12:60627200-60628600 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
17 | chr12:60628200-60628800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
18 | chr12:60628200-60628800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr12:60628400-60629400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
20 | chr12:60628600-60628800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
21 | chr12:60628600-60629200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
22 | chr12:60628600-60629400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
23 | chr12:60632600-60633200 | Enhancers | K562 | blood |
24 | chr12:60633200-60635800 | Weak transcription | K562 | blood |
25 | chr12:60635800-60636800 | Enhancers | K562 | blood |
26 | chr12:60644600-60645600 | Enhancers | Hela-S3 | cervix |